Skip to content

Combined Spinal-Epidural Temperature and Duration of Action

Effect of Temperature of Combined Spinal Epidural Dosing on Duration

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02020304
Enrollment
58
Registered
2013-12-24
Start date
2013-08-29
Completion date
2014-05-04
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Combined spinal epidural duration, labor pain

Brief summary

The hypothesis is that a combined spinal-epidural drug at refrigerated temperature will have a shorter period of pain relief than that maintained at room temperature. The temperature of the dose of medication will be measure with an infrared thermometer immediately prior (within 5 minutes) to administration.

Detailed description

Subjects will receive a combined spinal epidural medication as per standard of care to treat their labor pain; however, they will be randomized to receive either a dose maintained at room temperature (60-75 degrees F) or one maintained in a refrigerator (\ \<43 degrees F). Duration of action will be done by assessments of pain, vital signs, nausea, itching, bromage and fetal heart rate every 15 minutes until the subject requests additional pain medication to treat their labor pain.

Interventions

Combined Spinal Epidural

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* \>/= 18 years of age not allergic to medications used to treat labor pain \</= 6cm cervical dilation visual pain score \>/=3

Exclusion criteria

* \<18 years of age \> 6 cm cervical dilation non-English speaking subjects

Design outcomes

Primary

MeasureTime frameDescription
Timeup to 3 hourslength of time in minutes the combined spinal epidural dose duration is calculated from the time of administration until the request is made for additional analgesia (\ 1.5-3 hours) post dose. The subjects epidural is then dosed as per standard of care.

Secondary

MeasureTime frameDescription
Analgesia Onset-5 Minutes Post Injectionfrom time of CSE administration
Analgesia Onset-10 Minutes Post Injectionup to 3 hours
Analgesia Onset-15 Minutes Post Injectionup to 3 hours
Pruritus30 minutespatients reporting pruritis at 30 minutes after CSE injection, self reported and measured on a scale of 0 (no itching at all) up to 10 (itching as bad as can be imagined)

Countries

United States

Participant flow

Participants by arm

ArmCount
Room Temperature
room temperature combined spinal epidural dose (60-75 degrees F) combined spinal epidural: Combined Spinal Epidural
27
Refrigerated Temperature
refrigerated temperature combined spinal epidural dose (\ \<43 degrees F) combined spinal epidural: Combined Spinal Epidural
26
Total53

Baseline characteristics

CharacteristicRoom TemperatureRefrigerated TemperatureTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
27 Participants26 Participants53 Participants
Region of Enrollment
United States
27 participants26 participants53 participants
Sex: Female, Male
Female
27 Participants26 Participants53 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 270 / 26
other
Total, other adverse events
0 / 270 / 26
serious
Total, serious adverse events
0 / 270 / 26

Outcome results

Primary

Time

length of time in minutes the combined spinal epidural dose duration is calculated from the time of administration until the request is made for additional analgesia (\ 1.5-3 hours) post dose. The subjects epidural is then dosed as per standard of care.

Time frame: up to 3 hours

ArmMeasureValue (MEAN)Dispersion
Room TemperatureTime74 minutesStandard Deviation 29
Refrigerated TemperatureTime81 minutesStandard Deviation 32
Secondary

Analgesia Onset-10 Minutes Post Injection

Time frame: up to 3 hours

Population: number of subjects who achieved a VAS pain score of \</= 3 at 10 minutes after CSE injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Room TemperatureAnalgesia Onset-10 Minutes Post Injection25 Participants
Refrigerated TemperatureAnalgesia Onset-10 Minutes Post Injection19 Participants
Secondary

Analgesia Onset-15 Minutes Post Injection

Time frame: up to 3 hours

Population: number of subjects who achieved a VAS pain score of \</= 3 at 15 minutes after injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Room TemperatureAnalgesia Onset-15 Minutes Post Injection25 Participants
Refrigerated TemperatureAnalgesia Onset-15 Minutes Post Injection24 Participants
Secondary

Analgesia Onset-5 Minutes Post Injection

Time frame: from time of CSE administration

Population: number of subjects who achieved a VAS pain score of \</=3 at 5 minutes after CSE injection

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Room TemperatureAnalgesia Onset-5 Minutes Post Injection24 Participants
Refrigerated TemperatureAnalgesia Onset-5 Minutes Post Injection14 Participants
Secondary

Pruritus

patients reporting pruritis at 30 minutes after CSE injection, self reported and measured on a scale of 0 (no itching at all) up to 10 (itching as bad as can be imagined)

Time frame: 30 minutes

ArmMeasureValue (MEAN)Dispersion
Room TemperaturePruritus2 units on a scaleStandard Deviation 1
Refrigerated TemperaturePruritus1 units on a scaleStandard Deviation 2

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026